Pozelimab Active Not Recruiting Phase 2 Trials for Paroxysmal Nocturnal Haemoglobinuria (PNH) Treatment

Indications	Status	Purpose	Phase
DBCOND0079913 (Paroxysmal Nocturnal Haemoglobinuria (PNH))	Active Not Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04888507	Pozelimab and Cemdisiran Combination Therapy in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy	Cemdisiran (DB16121) Pozelimab (DB15218)
NCT04811716	Pozelimab and Cemdisiran Combination Treatment in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Received Pozelimab Monotherapy	Cemdisiran (DB16121) Pozelimab (DB15218)